4.8 Review

Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics

期刊

CELL
卷 184, 期 4, 页码 881-898

出版社

CELL PRESS
DOI: 10.1016/j.cell.2021.01.017

关键词

-

资金

  1. American Gastroenterological Association Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease
  2. NIH [5F31HL149334, 1R56EB027729-01A1, 1R01GM129011-01, R01EB029483, 1DP2CA186574]
  3. Paul G. Allen Frontiers Group
  4. Wyss Institute
  5. Boston University Ignition Award
  6. NSF [1522074]
  7. NSF CAREER [162457]
  8. NSF BBSRC [1614642]

向作者/读者索取更多资源

Synthetic biology is a design-driven discipline focused on engineering novel biological functions through the discovery and repurposing of molecular parts. Applications in vaccine development, molecular diagnostics, and cell-based therapeutics are already in clinical use or active clinical trials, with ongoing innovations likely to have a significant impact on future biomedicine applications.
Synthetic biology is a design-driven discipline centered on engineering novel biological functions through the discovery, characterization, and repurposing of molecular parts. Several synthetic biological solutions to critical biomedical problems are on the verge of widespread adoption and demonstrate the burgeoning maturation of the field. Here, we highlight applications of synthetic biology in vaccine development, molecular diagnostics, and cell-based therapeutics, emphasizing technologies approved for clinical use or in active clinical trials. We conclude by drawing attention to recent innovations in synthetic biology that are likely to have a significant impact on future applications in biomedicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据